TRIAMINIC-D MULTI-SYMPTOM COLD OTC
Generic Name and Formulations:
Chlorpheniramine maleate 1mg, dextromethorphan HBr 7.5mg, pseudoephedrine HCl 15mg; per 5mL; liq; grape flavor; contains sodium 6mg/5mL.
Novartis Consumer Health
Indications for TRIAMINIC-D MULTI-SYMPTOM COLD:
Nasal and sinus congestion. Cough. Rhinorrhea. Itchy nose or throat.
<4yrs: do not use. 4–6yrs: individualize. 6–12yrs: 10mL every 6 hours as needed. Max 4 doses/24hrs.
Children <4yrs old. During or within 14 days of MAOIs. Use as a sedative hypnotic.
Heart disease. Hypertension. Thyroid disease. Diabetes. Glaucoma. Asthma. Lower respiratory disorders. Discontinue if symptoms worsen or persist for ≥7 days.
Antihistamine + antitussive + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase the pressor effects of sympathomimetics. Antihypertensives antagonized. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, nervousness, dizziness, insomnia, excitability in children.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Rapid Cycling Bipolar Disorder Associated With ADHD and Female Gender
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Symptom Trajectories Vary According to Language Development in Autism
- Quetiapine Exposure Does Not Appear to Increase Risk for Infant Malformations
- Selective Serotonin Reuptake Inhibitors May Increase Risk for Suboptimal Fetal Growth
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Prenatal Insecticide Exposure in Mother May Be Linked to Risk for Autism in Children